PT1347963E - Derivados de benzofurano e de benzotiofeno como inibidores selectivos da cox-2 - Google Patents
Derivados de benzofurano e de benzotiofeno como inibidores selectivos da cox-2Info
- Publication number
- PT1347963E PT1347963E PT01994723T PT01994723T PT1347963E PT 1347963 E PT1347963 E PT 1347963E PT 01994723 T PT01994723 T PT 01994723T PT 01994723 T PT01994723 T PT 01994723T PT 1347963 E PT1347963 E PT 1347963E
- Authority
- PT
- Portugal
- Prior art keywords
- benzofuran
- cox
- selective inhibitors
- benzotiophene
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25128300P | 2000-12-05 | 2000-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1347963E true PT1347963E (pt) | 2004-12-31 |
Family
ID=22951260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT01994723T PT1347963E (pt) | 2000-12-05 | 2001-11-26 | Derivados de benzofurano e de benzotiofeno como inibidores selectivos da cox-2 |
Country Status (16)
Country | Link |
---|---|
US (1) | US6433005B1 (pt) |
EP (1) | EP1347963B1 (pt) |
JP (1) | JP4212892B2 (pt) |
KR (1) | KR20030070054A (pt) |
CN (1) | CN1273460C (pt) |
AR (1) | AR035719A1 (pt) |
AT (1) | ATE274507T1 (pt) |
AU (2) | AU2002224890B2 (pt) |
BR (1) | BR0115963A (pt) |
CA (1) | CA2437048A1 (pt) |
DE (1) | DE60105195T2 (pt) |
ES (1) | ES2225641T3 (pt) |
MX (1) | MXPA03004398A (pt) |
PT (1) | PT1347963E (pt) |
WO (1) | WO2002046178A2 (pt) |
ZA (1) | ZA200303641B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999051587A1 (fr) * | 1998-04-01 | 1999-10-14 | Ono Pharmaceutical Co., Ltd. | Derives de thiophene condenses et medicaments contenant ceux-ci comme principe actif |
JP2001261674A (ja) * | 2000-03-22 | 2001-09-26 | Mitsui Chemicals Inc | ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬 |
HUP0302473A2 (hu) * | 2000-05-18 | 2003-11-28 | Daiichi Pharmaceutical Co., Ltd. | Új benzotiofénszármazékok |
AU2001268051A1 (en) * | 2000-06-28 | 2002-01-08 | Eli Lilly And Company | Spla2 inhibitors |
US7071220B2 (en) * | 2000-09-18 | 2006-07-04 | Toa Eiyo Ltd. | N-substituted benzothiophenesulfonamide derivatives |
EP1673373A2 (en) * | 2003-10-02 | 2006-06-28 | Salmedix, Inc. | Indole derivatives |
ATE555091T1 (de) | 2006-02-03 | 2012-05-15 | Bionomics Ltd | Substituierte benzofurane, benzothiophene, benzoselenophene und indole und ihre verwendung als tubulinpolymerisationsinhibitoren |
WO2008055808A1 (en) | 2006-11-09 | 2008-05-15 | F. Hoffmann-La Roche Ag | Indole and benzofuran 2-carboxamide derivatives |
AU2011202542A1 (en) | 2010-07-14 | 2012-02-02 | Indian Institute Of Science | Benzothiophene carboxamide compounds, composition and applications thereof |
CN103819371B (zh) * | 2012-11-16 | 2016-05-04 | 中国科学院大连化学物理研究所 | 一种对甲砜基苯甲醛的合成方法 |
CN103058988B (zh) * | 2012-12-31 | 2015-09-02 | 中国人民大学 | 苯并噻吩及其衍生物及其制备方法与应用 |
CN110903225B (zh) * | 2019-12-11 | 2021-11-09 | 苏州开元民生科技股份有限公司 | 一种对甲砜基苯甲醛的合成方法 |
KR102542698B1 (ko) * | 2022-04-05 | 2023-06-14 | 주식회사 베노바이오 | 신규한 벤조사이오펜 유도체 및 bet 억제제로서의 용도 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3331854A (en) * | 1964-12-14 | 1967-07-18 | American Cyanamid Co | Novel furan and thiophene compounds |
US4663347A (en) | 1983-10-31 | 1987-05-05 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis |
US4822803A (en) | 1983-10-31 | 1989-04-18 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis |
US4933351A (en) | 1983-10-31 | 1990-06-12 | Merck Frosst Canada, Inc. | Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis |
US4745127A (en) * | 1983-10-31 | 1988-05-17 | Merck Frosst Canada, Inc. | Benzyl esters of benzofuran-2-carboxylic acids useful as inhibitors of leukotriene biosynthesis |
DE3342624A1 (de) | 1983-11-25 | 1984-03-29 | Heinfried Dr. 4019 Monheim Grote | Benzaronderivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel |
US4621091A (en) | 1984-10-09 | 1986-11-04 | Merck & Co., Inc. | 3-hydroxybenzo[b]thiophene-2-sulfide derivatives compositions, and method of use therefor |
US5208253A (en) * | 1992-02-24 | 1993-05-04 | Warner-Lambert Company | 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo(b) thiophene-2-carboxamides as inhibitors of cell adhesion |
JPH09500130A (ja) | 1993-07-15 | 1997-01-07 | ワーナー−ランバート・コンパニー | 炎症性腸疾患の治療において用いる薬剤としてのベンゾチオフェンおよびベンゾフランおよび炎症をアッセイする方法 |
US5426113A (en) | 1994-04-08 | 1995-06-20 | Warner-Lambert Company | Method of preventing ulcer formation caused by nonsteroidal antiinflammatory drugs employing tetrazol-benzothiophene carboxamide compounds |
US5521213A (en) * | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
US5731342A (en) | 1996-02-22 | 1998-03-24 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
JP2000505455A (ja) * | 1996-02-22 | 2000-05-09 | イーライ・リリー・アンド・カンパニー | ベンゾチオフエン類、それらを含む製剤、および方法 |
-
2001
- 2001-11-26 PT PT01994723T patent/PT1347963E/pt unknown
- 2001-11-26 AU AU2002224890A patent/AU2002224890B2/en not_active Ceased
- 2001-11-26 DE DE60105195T patent/DE60105195T2/de not_active Expired - Fee Related
- 2001-11-26 ES ES01994723T patent/ES2225641T3/es not_active Expired - Lifetime
- 2001-11-26 CA CA002437048A patent/CA2437048A1/en not_active Abandoned
- 2001-11-26 AU AU2489002A patent/AU2489002A/xx active Pending
- 2001-11-26 WO PCT/EP2001/013716 patent/WO2002046178A2/en active IP Right Grant
- 2001-11-26 BR BR0115963-1A patent/BR0115963A/pt not_active IP Right Cessation
- 2001-11-26 AT AT01994723T patent/ATE274507T1/de not_active IP Right Cessation
- 2001-11-26 CN CNB01820077XA patent/CN1273460C/zh not_active Expired - Fee Related
- 2001-11-26 KR KR10-2003-7007600A patent/KR20030070054A/ko active IP Right Grant
- 2001-11-26 EP EP01994723A patent/EP1347963B1/en not_active Expired - Lifetime
- 2001-11-26 MX MXPA03004398A patent/MXPA03004398A/es active IP Right Grant
- 2001-11-26 JP JP2002547917A patent/JP4212892B2/ja not_active Expired - Fee Related
- 2001-12-03 US US10/006,349 patent/US6433005B1/en not_active Expired - Fee Related
- 2001-12-03 AR ARP010105603A patent/AR035719A1/es not_active Application Discontinuation
-
2003
- 2003-05-12 ZA ZA200303641A patent/ZA200303641B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2489002A (en) | 2002-06-18 |
BR0115963A (pt) | 2003-10-28 |
WO2002046178A3 (en) | 2002-10-10 |
US20020107280A1 (en) | 2002-08-08 |
AR035719A1 (es) | 2004-07-07 |
EP1347963A2 (en) | 2003-10-01 |
ZA200303641B (en) | 2004-08-12 |
KR20030070054A (ko) | 2003-08-27 |
ES2225641T3 (es) | 2005-03-16 |
CA2437048A1 (en) | 2002-06-13 |
CN1273460C (zh) | 2006-09-06 |
JP2004517088A (ja) | 2004-06-10 |
AU2002224890B2 (en) | 2007-03-22 |
EP1347963B1 (en) | 2004-08-25 |
WO2002046178A2 (en) | 2002-06-13 |
JP4212892B2 (ja) | 2009-01-21 |
ATE274507T1 (de) | 2004-09-15 |
DE60105195D1 (de) | 2004-09-30 |
CN1479736A (zh) | 2004-03-03 |
MXPA03004398A (es) | 2003-09-05 |
DE60105195T2 (de) | 2005-09-08 |
US6433005B1 (en) | 2002-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR028576A1 (es) | Derivados de b-carbolina utiles como inhibidores de fosfodiesterasa | |
AR028575A1 (es) | Derivados de pirrolopiridinona utiles como inhibidores de fosfodiesterasa | |
PT1268480E (pt) | Derivados de 8-quinolinil-xantina e 8-isoquinolinil-xantina como inibidores da pde 5 | |
PT1287001E (pt) | Derivados de tiofeno uteis como agentes anticancerigenos | |
MA26060A1 (fr) | Nouveaux derives de pyrazolopyridine | |
FR12C0007I2 (fr) | Nouveaux derives de phenyle-propargylether | |
DZ3439A1 (fr) | Derives de 2-aminocarbonyl-9h-purine | |
PT1244647E (pt) | Derivados de quinazolina como inibidores de vegf | |
PT1303521E (pt) | Derivados de tetra-hidro-heterocicloazepinil-pirimidina | |
AR028596A1 (es) | Nuevos derivados de fenilglicina | |
PT1178986E (pt) | Derivados da furanona como inibidores da catepsina s | |
AR027967A1 (es) | Derivados de esteres de pirazol como agentes antinflamatorios/analgesicos | |
PT1097127E (pt) | Derivados de diacil-hidrazina como inibidores da integrina | |
MXPA03001848A (es) | Derivados de fenoxibencilamina como inhibidores de la reabsorcion de serotonina. | |
PT1212320E (pt) | Fenilpiperazinas como inibidores de reabsorcao de serotonina | |
PT1347963E (pt) | Derivados de benzofurano e de benzotiofeno como inibidores selectivos da cox-2 | |
ATE428695T1 (de) | Spirocyclische 3-phenyl-3-substituierte-4- ketolaktame und -laktone | |
PT1189907E (pt) | Tienopirimidinas como inibidores da fosfodiesterase | |
FR2810318B1 (fr) | Derives de diamano-phenothiazine | |
DE50114491D1 (de) | Substituierte C-Cyclohexylmethylamin-Derivative | |
AR028282A1 (es) | Derivados de aminofenil pirimidona | |
PT1377550E (pt) | Derivados eter fenil-heterociclilico como inibidores da recaptacao de serotonina. | |
PT1322592E (pt) | Derivados substituidos de 1-aminobutan-3-ol | |
PT1351959E (pt) | Novos derivados de pleuromutilina | |
PT1167260E (pt) | Derivados de vitamina d3 |